See accompanying commentary.

See accompanying commentary.Professor Peter M Rothwell, Stroke Prevention Research Unit, University Department of Clinical Neurology, Radcliffe Infirmary, Woodstock Road, OxfordPeripheral vascular events are those areas of the blood vessels supplying the of the body as the heart or brain.

The higher doses of PF – 03187207 demonstrated a clinically significant reduction in daily intraocular pressure from baseline and the highest dose showed consistently more IOP lowering than Xalatan 0, at all study visits and at all individual time points, suggesting a beneficial effect of nitric oxide donation. PF – 03187207 is a nitric oxide donating prostaglandin analog , which is covered by the companies August 2004 agreement.. glaucoma U.S. Phase 2a Results for PF – 03187207 and gives an update on continuing NO – prostaglandin ProgramNicOx SA announced the results of a U.S. Phase 2 trial, which, from its partner Pfizer Inc. In comparison performed the safety and efficacy of different doses of PF – 03187207 to Xalatan 0.005 percent in patients with primary open-angle glaucoma and ocular hypertension.To work tog Diagnostic system receives Australian TGA marketing authorization He CTLM.

Imaging Diagnostic Systems, , a pioneer in laser optic imaging of the breast, today announced that that the Australian Government Department of Health and Ageing Therapeutic Goods Administration did CT laser mammogram approved by the system of for inclusion on Australian register of Therapeutic Goods . Therapeutic Goods Administration Therapeutic Goods Administration , to include all medicinal appliances to the register in before placing the units be sold Australian.